LPM-3480226 | Interleukin Related interleukin-related.com

Product Name :
LPM-3480226

Search keywords :
Tryptophanase

drugId :
null

Target Vo:
Tryptophan 2,3-dioxygenase

Target Vo Short Name :
TDO2

Moa_Name:
Indoleamine 2,3-dioxygenase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Luye Pharma Group Ltd

Active Company_Name :
Luye Pharma Group Ltd

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD9 Rabbit mAb medchemexpress
TrkB Rabbit mAb Description
CD68 Antibody (YA798): CD68 Antibody (YA798) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa., targeting to CD68. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts